TrialDiabetes, obesity & metabolism2017

Insulin degludec: Lower day-to-day and within-day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes.

Tim Heise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.